美国 · 平台与数据 · The Motley Fool

Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?

来源：The Motley Fool · 美国 34 分钟前

Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027? — Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027? · The Motley Fool

详细摘要

Bristol Myers trades at under 10 times forward earnings, while Vertex commands nearly triple that multiple, but its margins are roughly double.

在 The Motley Fool 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.fool.com)

推荐阅读

How much in Roth conversions can you do in 2027 with the new tax brackets?

Berkshire Hathaway more than doubles buybacks in third quarter as earnings decline

Heavy rain floods tents housing Gaza displaced people, aid shortages hamper response

Best Stocks Under $5

Just 13.8% of American Families Own a Second Home or Other Residential Property. The Typical One Is Worth $280,000

Fed rate call leaves stock investors watching December closely